Vasopressin inhibits endotoxin-induced upregulation of inflammatory mediators in activated macrophages

Tzu Chi Medical Journal

Volumn 25, Issue 3, 2013, Pages 150-154

  Peng, Tsui Chin ^a,b   Huang, Chun Jen ^a,b  

^a BUDDHIST TZU CHI GENERAL HOSPITAL   (Taiwan)

^b TZU CHI UNIVERSITY   (Taiwan)

Author keywords

Chemokine; Cytokine; Lipopolysaccharide; Nitric oxide; Prostaglandin E2

Indexed keywords

CYCLOOXYGENASE 2; ENDOTOXIN; INTERLEUKIN 1BETA; INTERLEUKIN 6; LIPOPOLYSACCHARIDE; MACROPHAGE INFLAMMATORY PROTEIN 2; MESSENGER RNA; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; PROSTAGLANDIN E2; TUMOR NECROSIS FACTOR ALPHA; VASOPRESSIN;

ANIMAL CELL; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DOSE RESPONSE; DRUG INHIBITION; IMMUNOMODULATION; INFLAMMATORY MEDIATOR; MACROPHAGE ACTIVATION; MACROPHAGE CULTURE; MEDIATOR; NONHUMAN; UPREGULATION;

EID: 84883790310     PISSN: 10163190     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tcmj.2013.04.003     Document Type: Article

References (30)

1. Walley K.R., Lukacs N.W., Standiford T.J., Strieter R.M., Kunkel S.L. Elevated levels of macrophage inflammatory protein 2 in severe murine peritonitis increase neutrophil recruitment and mortality. Infect Immun 1997, 65:3847-3851.
2. Blackwell T.S., Christman J.W. Sepsis and cytokines: current status. Br J Anaesth 1996, 77:110-117.
3. Nussler A.K., Billiar T.R. Inflammation, immunoregulation, and inducible nitric oxide synthase. JLeukoc Biol 1993, 54:171-178.
4. Haveman J.W., Muller Kobold A.C., Tervaert J.W., van den Berg A.P., Tulleken J.E., Kallenberg C.G., et al. The central role of monocytes in the pathogenesis of sepsis: consequences for immunomonitoring and treatment. Neth J Med 1999, 55:132-141.
5. Aziz M., Jacob A., Yang W.L., Matsuda A., Wang P. Current trends in inflammatory and immunomodulatory mediators in sepsis. JLeukoc Biol 2013, 93:329-342.
6. Yoshinari D., Takeyoshi I., Koibuchi Y., Matsumoto K., Kawashima Y., Koyama T., et al. Effects of a dual inhibitor of tumor necrosis factor-alpha and interleukin-1 on lipopolysaccharide-induced lung injury in rats: involvement of the p38 mitogen-activated protein kinase pathway. Crit Care Med 2001, 29:628-634.
7. Su C.F., Yang F.L., Chen H.I. Inhibition of inducible nitric oxide synthase attenuates acute endotoxin-induced lung injury in rats. Clin Exp Pharmacol Physiol 2007, 34:339-346.
8. Riddell D.C., Mallonee R., Phillips J.A., Parks J.S., Sexton L.A., Hamerton J.L. Chromosomal assignment of human sequences encoding arginine vasopressin-neurophysin II and growth hormone releasing factor. Somat Cell Mol Genet 1985, 11:189-195.
9. Sklar A.H., Schrier R.W. Central nervous system mediators of vasopressin release. Physiol Rev 1983, 63:1243-1280.
10. Landry D.W., Levin H.R., Gallant E.M., Ashton R.C., Seo S., D'Alessandro D., et al. Vasopressin deficiency contributes to the vasodilation of septic shock. Circulation 1997, 95:1122-1125.
11. Sharshar T., Blanchard A., Paillard M., Raphael J.C., Gajdos P., Annane D. Circulating vasopressin levels in septic shock. Crit Care Med 2003, 31:1752-1758.
12. Lin I.Y., Ma H.P., Lin A.C., Chong C.F., Lin C.M., Wang T.L. Low plasma vasopressin/norepinephrine ratio predicts septic shock. Am J Emerg Med 2005, 23:718-724.
13. Landry D.W., Levin H.R., Gallant E.M., Seo S., D'Alessandro D., Oz M.C., et al. Vasopressin pressor hypersensitivity in vasodilatory septic shock. Crit Care Med 1997, 25:1279-1282.
14. Baker C.H., Sutton E.T., Zhou Z., Dietz J.R. Microvascular vasopressin effects during endotoxin shock in the rat. Circ Shock 1990, 30:81-95.
15. Albert M., Losser M.R., Hayon D., Faivre V., Payen D. Systemic and renal macro- and microcirculatory responses to arginine vasopressin in endotoxic rabbits. Crit Care Med 2004, 32:1891-1898.
16. Kopel T., Losser M.R., Faivre V., Payen D. Systemic and hepatosplanchnic macro- and microcirculatory dose response to arginine vasopressin in endotoxic rabbits. Intensive Care Med 2008, 34:1313-1320.
17. Dellinger R.P., Levy M.M., Rhodes A., Annane D., Gerlach H., Opal S.M., et al. Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock, 2012. Intensive Care Med 2013, 39:165-228.
18. Boyd J.H., Holmes C.L., Wang Y., Roberts H., Walley K.R. Vasopressin decreases sepsis-induced pulmonary inflammation through the V2R. Resuscitation 2008, 79:325-331.
19. Jones E., Adcock I.M., Ahmed B.Y., Punchard N.A. Modulation of LPS stimulated NF-kappaB mediated nitric oxide production by PKCepsilon and JAK2 in RAW macrophages. JInflamm (Lond) 2007, 4:23.
20. Tsai P.S., Chen C.C., Tsai P.S., Yang L.C., Huang W.Y., Huang C.J. Heme oxygenase 1, nuclear factor E2-related factor 2, and nuclear factor kappaB are involved in hemin inhibition of type 2 cationic amino acid transporter expression and L-arginine transport in stimulated macrophages. Anesthesiology 2006, 105:1201-1210.
21. + channel. Anesth Analg 2006, 102:1739-1744.
22. Futaki N., Takahashi S., Kitagawa T., Yamakawa Y., Tanaka M., Higuchi S. Selective inhibition of cyclooxygenase-2 by NS-398 in endotoxin shock rats invivo. Inflamm Res 1997, 46:496-502.
23. Blackwell T.S., Christman J.W. The role of nuclear factor-kappa B in cytokine gene regulation. Am J Respir Cell Mol Biol 1997, 17:3-9.
24. Chen C., Chen Y.H., Lin W.W. Involvement of p38 mitogen-activated protein kinase in lipopolysaccharide-induced iNOS and COX-2 expression in J774 macrophages. Immunology 1997, 97:124-129.
25. Asehnoune K., Strassheim D., Mitra S., Kim J.Y., Abraham E. Involvement of reactive oxygen species in Toll-like receptor 4-dependent activation of NF-kappa B. JImmunol 2004, 172:2522-2529.
26. Chi H., Barry S.P., Roth R.J., Wu J.J., Jones E.A., Bennett A.M., et al. Dynamic regulation of pro- and anti-inflammatory cytokines by MAPK phosphatase 1 (MKP-1) in innate immune responses. Proc Natl Acad Sci USA 2006, 103:2274-2279.
27. Heumann D., Roger T. Initial responses to endotoxins and Gram-negative bacteria. Clin Chim Acta 2002, 323:59-72.
28. Schmidt C., Hocherl K., Kurt B., Bucher M. Role of nuclear factor-kappaB-dependent induction of cytokines in the regulation of vasopressin V1A-receptors during cecal ligation and puncture-induced circulatory failure. Crit Care Med 2008, 36:2363-2372.
29. Birnbaumer M. Vasopressin receptors. Trends Endocrinol Metab 2000, 11:406-410.
30. Bucher M., Hobbhahn J., Taeger K., Kurtz A. Cytokine-mediated downregulation of vasopressin V(1A) receptors during acute endotoxemia in rats. Am J Physiol Regul Integr Comp Physiol 2002, 282:R979-R984.